Metraipolis › archive › dc_669e2f136906
Revolutionizing cancer immunotherapy: T cell engagers beyond hematologic malignancies toward solid tumors — Europe PMC PMID:42245672
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42245672
- DOI
- 10.3389/fimmu.2026.1774471
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T13:26:57.552Z
- SHA-256 of the archived text
b4cef5c539fe132a021c8abb946f82b803426e46f1fe853fbd45acf72d9a418c- Stable URL of this page
https://metraipolis.com/documento/dc_669e2f136906
How to cite
Revolutionizing cancer immunotherapy: T cell engagers beyond hematologic malignancies toward solid tumors — Europe PMC PMID:42245672 — Europe PMC (en), https://europepmc.org/article/MED/42245672 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_669e2f136906 (Metraipolis archive dc_669e2f136906, sha256 b4cef5c539fe132a021c8abb946f82b803426e46f1fe853fbd45acf72d9a418c)
BibTeX
@misc{dc669e2f136906,
title = {Revolutionizing cancer immunotherapy: T cell engagers beyond hematologic malignancies toward solid tumors — Europe PMC PMID:42245672},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42245672},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_669e2f136906; sha256 b4cef5c539fe132a021c8abb946f82b803426e46f1fe853fbd45acf72d9a418c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42245672. Agents can read the archived copy with the MCP tool read_document.